Wouter H Bos

2.3k total citations
39 papers, 1.4k citations indexed

About

Wouter H Bos is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, Wouter H Bos has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Rheumatology, 10 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Hematology. Recurrent topics in Wouter H Bos's work include Rheumatoid Arthritis Research and Therapies (24 papers), Systemic Lupus Erythematosus Research (17 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Wouter H Bos is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (24 papers), Systemic Lupus Erythematosus Research (17 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Wouter H Bos collaborates with scholars based in Netherlands, United States and Canada. Wouter H Bos's co-authors include Dirkjan van Schaardenburg, Lotte A van de Stadt, Ben A. C. Dijkmans, R J van de Stadt, Maarten Boers, Gertjan Wolbink, Birgit I. Lissenberg‐Witte, B. A. C. Dijkmans, Conny J. van der Laken and Michael T. Nurmohamed and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and International Journal of Environmental Research and Public Health.

In The Last Decade

Wouter H Bos

39 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wouter H Bos Netherlands	20	1.2k	326	321	202	133	39	1.4k
I. Speyer Netherlands	15	1.3k 1.1×	173 0.5×	484 1.5×	171 0.8×	256 1.9×	25	1.5k
Carolyn Neville Canada	20	961 0.8×	104 0.3×	311 1.0×	362 1.8×	89 0.7×	40	1.3k
Catharina Eriksson Sweden	18	759 0.7×	197 0.6×	149 0.5×	499 2.5×	59 0.4×	31	1.4k
André J. Peeters Netherlands	12	1.8k 1.5×	213 0.7×	707 2.2×	200 1.0×	312 2.3×	15	2.0k
A. Stirling United Kingdom	10	1.3k 1.1×	96 0.3×	556 1.7×	219 1.1×	238 1.8×	14	1.5k
Beverley Harrison United Kingdom	20	1.5k 1.3×	191 0.6×	479 1.5×	397 2.0×	157 1.2×	29	1.9k
Linda T. Hiraki Canada	20	1.7k 1.5×	267 0.8×	358 1.1×	849 4.2×	71 0.5×	65	2.2k
Kari Puolakka Finland	23	1.5k 1.3×	96 0.3×	601 1.9×	361 1.8×	259 1.9×	86	1.9k
E. J. ter Borg Netherlands	24	1.6k 1.4×	458 1.4×	364 1.1×	651 3.2×	178 1.3×	46	2.2k
Alfred Cividino Canada	19	833 0.7×	89 0.3×	270 0.8×	231 1.1×	84 0.6×	33	1.5k

Countries citing papers authored by Wouter H Bos

Since Specialization

Citations

This map shows the geographic impact of Wouter H Bos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter H Bos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter H Bos more than expected).

Fields of papers citing papers by Wouter H Bos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter H Bos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter H Bos. The network helps show where Wouter H Bos may publish in the future.

Co-authorship network of co-authors of Wouter H Bos

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter H Bos. A scholar is included among the top collaborators of Wouter H Bos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter H Bos. Wouter H Bos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seppen, Bart, Marjolein J.E. Greuter, Marieke M. ter Wee, et al.. (2023). Self-monitoring combined with patient-initiated care in RA patients with low disease activity: cost-effectiveness analysis of an RCT. Lara D. Veeken. 62(10). 3366–3372. 3 indexed citations

Seppen, Bart, et al.. (2023). Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inflammatory arthritis. Rheumatology International. 43(4). 677–685. 10 indexed citations

Seppen, Bart, et al.. (2023). Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study. Rheumatology International. 43(4). 651–657. 3 indexed citations

Seppen, Bart, Marieke M. ter Wee, Dirkjan van Schaardenburg, et al.. (2022). Smartphone‐Assisted Patient‐Initiated Care Versus Usual Care in Patients With Rheumatoid Arthritis and Low Disease Activity: A Randomized Controlled Trial. Arthritis & Rheumatology. 74(11). 1737–1745. 41 indexed citations

Seppen, Bart, et al.. (2022). Who stop telemonitoring disease activity and who adhere: a prospective cohort study of patients with inflammatory arthritis. BMC Rheumatology. 6(1). 73–73. 7 indexed citations

Boekel, Laura, Femke Hooijberg, Erik H Vogelzang, et al.. (2022). COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases. The Lancet Rheumatology. 4(5). e310–e313. 12 indexed citations

Boheemen, Laurette van, Samina A. Turk, Marian H. van Beers-Tas, et al.. (2021). Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial. RMD Open. 7(1). e001591–e001591. 41 indexed citations

Bos, Wouter H, Astrid van Tubergen, & Harald E. Vonkeman. (2021). Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands. Rheumatology International. 41(3). 565–573. 49 indexed citations

Boekel, Laura, Femke Hooijberg, Erik H Vogelzang, et al.. (2021). Spinning straw into gold: description of a disruptive rheumatology research platform inspired by the COVID-19 pandemic. Arthritis Research & Therapy. 23(1). 207–207. 6 indexed citations

10.

Seppen, Bart, et al.. (2020). Feasibility of Self-Monitoring Rheumatoid Arthritis With a Smartphone App: Results of Two Mixed-Methods Pilot Studies. JMIR Formative Research. 4(9). e20165–e20165. 39 indexed citations

11.

Seppen, Bart, Marieke M. ter Wee, Marike van der Leeden, et al.. (2020). Asynchronous mHealth Interventions in Rheumatoid Arthritis: Systematic Scoping Review. JMIR mhealth and uhealth. 8(11). e19260–e19260. 37 indexed citations

12.

Seppen, Bart, Marieke M. ter Wee, Franktien Turkstra, et al.. (2019). A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled Trial. SHILAP Revista de lepidopterología. 9(2). e15105–e15105. 14 indexed citations

13.

Limper, Maarten, Wouter H Bos, Martijn D. de Kruif, et al.. (2012). The Acute-phase Response Is Not Predictive for the Development of Arthritis in Seropositive Arthralgia – A Prospective Cohort Study. The Journal of Rheumatology. 39(10). 1914–1917. 12 indexed citations

14.

Stadt, Lotte A van de, Birgit I. Lissenberg‐Witte, Wouter H Bos, & Dirkjan van Schaardenburg. (2012). A prediction rule for the development of arthritis in seropositive arthralgia patients. Annals of the Rheumatic Diseases. 72(12). 1920–1926. 179 indexed citations

15.

Raterman, Hennie G., Anna Jamnitski, Willem F. Lems, et al.. (2010). Improvement of Thyroid Function in Hypothyroid Patients with Rheumatoid Arthritis After 6 Months of Adalimumab Treatment: A Pilot Study. The Journal of Rheumatology. 38(2). 247–251. 30 indexed citations

16.

Bos, Wouter H, Gertjan Wolbink, Maarten Boers, et al.. (2009). Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Annals of the Rheumatic Diseases. 69(3). 490–494. 208 indexed citations

17.

Ursum, Jennie, Wouter H Bos, Rob J. van de Stadt, Ben A. C. Dijkmans, & Dirkjan van Schaardenburg. (2009). Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems. Arthritis Research & Therapy. 11(3). R75–R75. 41 indexed citations

18.

Bos, Wouter H, Jennie Ursum, Niek de Vries, et al.. (2008). The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels. Annals of the Rheumatic Diseases. 67(9). 1347–1350. 22 indexed citations

19.

Bos, Wouter H, G. M. Bartelds, Marijn Vis, et al.. (2008). Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 68(4). 558–563. 24 indexed citations

20.

Bos, Wouter H, et al.. (2006). Bullous pemphigoid successfully controlled by tetracycline and nicotinamide. British Journal of Dermatology. 133(1). 88–90. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact